The high cost of these drugs prevents them from being widely used, especially in areas with lower incomes
Limited RCTs have been published thus far on patient populations with hypertension specifically, with blood pressure variations being measured as a primary endpoint and tracked long-term
Oral formulations of GLP-1 agonists, including oral semaglutide and oral tirzepatide , create different pharmacokinetic profiles than injections
Another oral GLP-1 drug, orforglipron (Foundayo) has just been approved by the FDA for weight management
Animal studies suggest GLP-1 signaling in the brain may help recalibrate sleep-wake cycles entirely independent of body weight changes, though these findings have not yet been replicated in humans (ref)
CrossRef Geospatial patterns and socioeconomic determinants of the global acute viral hepatitis burden Ke-Jie He, Guoyu Gong Frontiers in Public Health .2025;[Epub] CrossRef Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis Shan Ren, Sujun Zheng, Xinyang Zhang, Junliang Fu, Rongshan Fan, Qingfa Ruan, Wenqi Huang, Haibing Gao, Xiulan Xue, Fang Yang, Yao Xie, Minghui Li, Xinyue Chen Virology Journal .2025;[Epub] CrossRef Evaluating Non-Invasive Biomarkers and Composite Scores for Liver Fibrosis Diagnosis in Hepatitis B and C Infections Tamer A